oMeds
All answers
Answer · metabolic

Which pathway addresses stubborn belly fat?

Short answer

Central adiposity is routed by metabolic and hormonal context. BMI-eligible candidates with insulin resistance → GLP-1. Men with low testosterone and central adiposity → TRT in parallel. Peri/menopausal women → BHRT. Lipo-B is adjunct.

Reviewed by Dr. Laura PurdyMay 29, 2026

Full answer

Visceral adiposity is the most cardiometabolically harmful fat depot. Provider review reads fasting insulin, A1C, lipids, ApoB, total/free testosterone, estradiol, and cortisol context. BMI-eligible candidates with insulin resistance or weight-related comorbidities are routed to GLP-1 pathways. Men with confirmed low testosterone and central adiposity are evaluated for Testosterone Optimization in parallel. Peri/menopausal women with matching biomarkers are evaluated for BHRT. Lipo-B is an adjunct, never a primary pathway. Every plan is synchronous-video reviewed.

Educational. Not a substitute for individualized provider review.

References & sources
  • Glp1 Semaglutide pathway — Primary source · oMeds
  • Reviewed by Dr. Laura Purdy, MD, MBA · Clinical Director, oMeds · Last reviewed 2026-05-29